Genomine Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

Genomine General Information

Description

Operator of a research and development company intended to discover functional genes for biotechnological procedures. The company's services include discovering disease markers that are based on functional dielectric, proteome analysis and create added value through technology transfer that are utilized in businesses, alongside focusing on discovering novel plant genes related to yield increase, environmental stress, and lethality, thereby enabling researchers and agriculture owners to transform crop and crop protection crab business based on gene discovery and utilization technology.

Contact Information

Website
www.genomine.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Primary Office
  • Number 306, Pohang Technopark 1 Venture-dong
  • 394 Jigok-ro, Nam-gu
  • Pohang-si, Gyeongsangbuk-do
  • South Korea
+82 000-000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genomine Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Secondary Transaction - Private 01-Jan-2022 Completed Generating Revenue
1. Early Stage VC 02-Jul-2000 Completed Generating Revenue
To view Genomine’s complete valuation and funding history, request access »

Genomine Patents

  • 54

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Genomine Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2894474-A4 Method and kit for detecting renal cancer blood biomarkers Active 07-Sep-2012 000000000000 0
EP-2894474-A1 Method and kit for detecting renal cancer blood biomarkers Active 07-Sep-2012 000000000000
EP-2894474-B1 Use of specific binding molecules and of respective kit for detecting renal cancer blood biomarkers Active 07-Sep-2012 000000000000
US-20110131683-A1 Polypeptide inducing dwarfism of plants, polynucleotide coding the polypeptide, and those use Inactive 13-Nov-2007 0000000000
EP-2115142-A1 Polypeptide having methionine synthesis function, polynucleotide encoding the polypeptide, and those use Inactive 19-Dec-2006 C12N9/88
To view Genomine’s complete patent history, request access »

Genomine Executive Team (3)

Name Title Board Seat Contact Info
Dongsoo Kim Chief Executive Officer
You’re viewing 1 of 3 executive team members. Get the full list »

Ready to get started?

Request a free trial